ResearcherUnited States Department of Veterans AffairsActive in the last 2 years
Dongfeng Qu
Matched on ORCID iD 0000-0002-9200-3852; OpenAlex author ID A5005932326; NIH RePORTER profile ID 11834965. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 2, last author 0)
- Trials
- 0
- Grants
- 1
- Labs led
- 1
- Collaborators
- 16
2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 grant · 2023: none · 2024: none · 2025: 1 paper
Papers 6
- A novel D-peptide modulates DCLK1 gelsolin interactions, reducing PDAC tumor growth. First author DOI 10.1038/s41598-025-19722-z↗
- Tuft cells: an emerging therapeutic target for pancreatitis and pancreatic cancer? Co-author DOI 10.1080/14728222.2020.1841168↗
- Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to Inhibit Tumorigenesis in Pancreatic Cance… Co-author DOI 10.1155/2019/6402925↗
- Doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells. Co-author DOI 10.1371/journal.pone.0118933↗
- Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase… First author DOI 10.1186/1476-4598-13-103↗
- DCLK1 regulates pluripotency and angiogenic factors via microRNA-dependent mechanisms in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0073940↗
Grants 1
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Courtney W. Houchen · 5 shared papers, 2013–2025 · strength 0.46
- Paper A novel D-peptide modulates DCLK1 gelsolin interactions, reducing PDAC tumor growth. DOI 10.1038/s41598-025-19722-z↗
- Paper Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to I… DOI 10.1155/2019/6402925↗
- Paper Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer throug… DOI 10.1186/1476-4598-13-103↗
- Nathaniel Weygant · 5 shared papers, 2013–2020 · strength 0.34
- Paper Tuft cells: an emerging therapeutic target for pancreatitis and pancreatic cancer? DOI 10.1080/14728222.2020.1841168↗
- Paper Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to I… DOI 10.1155/2019/6402925↗
- Paper Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer throug… DOI 10.1186/1476-4598-13-103↗
- Landon L. Moore · 1 shared paper, 2025 · strength 0.27
- Yuning Yang · 1 shared paper, 2020 · strength 0.15
- Guangyu An · 2 shared papers, 2015–2019 · strength 0.12
- Paper Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to I… DOI 10.1155/2019/6402925↗
- Paper Doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circul… DOI 10.1371/journal.pone.0118933↗
- Ben Z. Stanger · 2 shared papers, 2015–2019 · strength 0.12
- Paper Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to I… DOI 10.1155/2019/6402925↗
- Paper Doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circul… DOI 10.1371/journal.pone.0118933↗
- Sripathi M. Sureban · 3 shared papers, 2013–2015 · strength 0.11
- Paper Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer throug… DOI 10.1186/1476-4598-13-103↗
- Paper Doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circul… DOI 10.1371/journal.pone.0118933↗
- Paper DCLK1 regulates pluripotency and angiogenic factors via microRNA-dependent mechanisms in pancreatic cancer. DOI 10.1371/journal.pone.0073940↗
- Min Li · 1 shared paper, 2019 · strength 0.08
- Timothy Cragin Wang · 1 shared paper, 2019 · strength 0.08
- Ralf Janknecht · 1 shared paper, 2014 · strength 0.04
- James Randolph Sanders Hocker · 1 shared paper, 2015 · strength 0.04
- Nicole M. Aiello · 1 shared paper, 2015 · strength 0.04
- Jay S. Hanas · 1 shared paper, 2015 · strength 0.04
- Andrew D. Rhim · 1 shared paper, 2015 · strength 0.04
- Shubham Pant · 1 shared paper, 2015 · strength 0.04
- Chinthalapally V. Rao · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.